首页> 美国卫生研究院文献>JIMD Reports >Diaphragmatic Eventration in Sisters with Asparagine Synthetase Deficiency: A Novel Homozygous ASNS Mutation and Expanded Phenotype
【2h】

Diaphragmatic Eventration in Sisters with Asparagine Synthetase Deficiency: A Novel Homozygous ASNS Mutation and Expanded Phenotype

机译:与天冬酰胺合成酶缺乏症的姐妹的ph肌事件:一种新型的纯合子ASNS突变和扩展的表型。

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Background: Asparagine Synthetase Deficiency (ASNSD; OMIM #615574) is a newly described rare autosomal recessive neurometabolic disorder, characterised by congenital microcephaly, severe psychomotor delay, encephalopathy and progressive cerebral atrophy. To date, seven families and seven missense mutations in the ASNSD disease causing gene, ASNS, have been published. Methods: We report two further affected infant sisters from a consanguineous Indian family, who in addition to the previously described features had diaphragmatic eventration. Both girls died within the first 6 months of life. Whole exome sequencing (WES) was performed for both sisters to identify the pathogenic mutation. The clinical and biochemical parameters of our patient are compared to previous reports. Results: WES demonstrated a homozygous novel missense ASNS mutation, c.1019G > A, resulting in substitution of the highly conserved arginine residue by histidine (R340H). Conclusion: This report expands the phenotypic and mutation spectrum of ASNSD, which should be considered in neonates with congenital microcephaly, seizures and profound neurodevelopmental delay. The presence of diaphragmatic eventration suggests extracranial involvement of the central nervous system in a disorder that was previously thought to exclusively affect the brain. Like all previously reported patients, these cases were diagnosed with WES, highlighting the clinical utility of next generation sequencing in the diagnosis of rare, difficult to recognise disorders. >Electronic supplementary material: The online version of this chapter (doi:10.1007/8904_2016_3) contains supplementary material, which is available to authorized users.
机译:背景:天冬酰胺合成酶缺乏症(ASNSD; OMIM#615574)是一种新近描述的罕见的常染色体隐性遗传性神经代谢疾病,其特征为先天性小头畸形,严重的精神运动迟缓,脑病和进行性脑萎缩。迄今为止,已经发表了ASNSD致病基因ASNS中的七个家族和七个错义突变。方法:我们报告了来自印度近亲家庭的两个受影响的婴儿姐妹,他们除了先前描述的特征外还有diaphragm肌diaphragm动。两个女孩都在生命的头6个月内死亡。对两个姐妹都进行了全外显子组测序(WES),以鉴定致病突变。我们的患者的临床和生化参数与以前的报告进行了比较。结果:WES显示出纯合的新型错义ASNS突变,c.1019G→A,导致组氨酸(R340H)取代了高度保守的精氨酸残基。结论:本报告扩大了ASNSD的表型和突变谱,这对于先天性小头畸形,癫痫发作和严重的神经发育延迟的新生儿应予以考虑。 diaphragm肌event裂的存在提示中枢神经系统参与了颅外受累,这种疾病以前被认为仅影响大脑。像所有先前报道的患者一样,这些病例被诊断出患有WES,突出了下一代测序技术在罕见,难以识别的疾病诊断中的临床应用。 >电子补充材料::本章的在线版本(doi:10.1007 / 8904_2016_3)包含补充材料,授权用户可以使用。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号